“It’ll be a jackpot to launch Champix generic,’ leading patent challenges

Since Pfizer’s antismoking treatment, ‘Champix(varenicline tartrate)’ become a gigantic product with the government’s drug price support, Korean pharmaceutical companies have tried to launch its generic.

However, its patent valid until July 19, 2020, has interrupted the hope of the companies.

Dong Wha Pharm challenged to the patent, but failed. Recently, CorePharm Bio attracted attention of...